March 10th 2023
The new guidance is the first update since 2008, replacing the previous risk-based recommendations.
Test Your Knowledge: Can you Diagnose these Vulvar Diseases?
June 21st 2013Vulvovaginal disease is common, but often difficult to diagnose. Yeast infections, vulvodynia, and contact dermatitis may be easy to identify, but chronic or overlapping conditions can be difficult to spot. Can you accurately diagnose these patients?
Read More
Local Estrogen Treatment Improves Sexual Satisfaction in Postmenopausal Women and their Partners
June 17th 2013After treating vaginal atrophy with local estrogens, sexual satisfaction for postmenopausal women and their male partners improves, according to the results of a survey published online in the journal Menopause.
Read More
Osphena Approved by FDA to Treat Dyspareunia
February 27th 2013Osphena (ospemifene) has been approved by the FDA to treat dyspareunia. This is the first non-steroidal estrogen available for women with dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy (VVA) that is common during menopause.
Read More
Managing Postmenopausal Symptoms With Nonpharmacological Therapies
February 1st 2013Certain herbal and complementary medicines may be a valuable treatment option for women with postmenopausal symptoms, according to a new review outlining the advantages and limitations of the available treatments of postmenopausal symptoms.
Read More
More Countries Report Cephalosporin-Resistant Gonorrhea
June 18th 2012The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.
Read More